{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:23:42Z","timestamp":1782815022565,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00066-023-02061-1","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T13:02:57Z","timestamp":1679058177000},"page":"828-837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Non-endometrioid endometrial cancer: analysis of recurrence pattern and identification of prognostic and treatment factors affecting recurrence and survival"],"prefix":"10.1007","volume":"199","author":[{"given":"So Jung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo-Kang","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myungsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"2061_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","volume":"366","author":"F Amant","year":"2005","unstructured":"Amant\u00a0F, Moerman\u00a0P, Neven\u00a0P et\u00a0al (2005) Endometrial cancer. Lancet 366:491\u2013505","journal-title":"Lancet"},{"key":"2061_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel\u00a0RL, Miller\u00a0KD, Jemal\u00a0A (2016) Cancer statistics, 2016. Ca Cancer J Clin 66:7\u201330","journal-title":"Ca Cancer J Clin"},{"key":"2061_CR3","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMra1514010","volume":"383","author":"KH Lu","year":"2020","unstructured":"Lu\u00a0KH, Broaddus\u00a0RR (2020) Endometrial cancer. N\u00a0Engl J Med 383:2053\u20132064","journal-title":"N Engl J Med"},{"key":"2061_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/107327480901600107","volume":"16","author":"A Mendivil","year":"2009","unstructured":"Mendivil\u00a0A, Schuler\u00a0KM, Gehrig\u00a0PA (2009) Non-endometrioid adenocarcinoma of the uterine corpus: a\u00a0review of selected histological subtypes. Cancer Control 16:46\u201352","journal-title":"Cancer Control"},{"key":"2061_CR5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s12094-022-02799-7","volume":"24","author":"MP Barretina-Ginesta","year":"2022","unstructured":"Barretina-Ginesta\u00a0MP, Quind\u00f3s\u00a0M, Alarc\u00f3n\u00a0JD et al (2022) SEOM-GEICO clinical guidelines on endometrial cancer (2021). Clin Transl Oncol 24:625\u2013634","journal-title":"Clin Transl Oncol"},{"key":"2061_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin\u00a0N, Matias-Guiu\u00a0X, Vergote\u00a0I et al (2021) ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 31:12\u201339","journal-title":"Int J Gynecol Cancer"},{"key":"2061_CR7","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","volume":"20","author":"SM de Boer","year":"2019","unstructured":"de Boer\u00a0SM, Powell\u00a0ME, Mileshkin\u00a0L et al (2019) Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a\u00a0randomised phase 3 trial. Lancet Oncol 20:1273\u20131285","journal-title":"Lancet Oncol"},{"key":"2061_CR8","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","volume":"380","author":"D Matei","year":"2019","unstructured":"Matei\u00a0D, Filiaci\u00a0V, Randall\u00a0ME et\u00a0al (2019) Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer. N\u00a0Engl J Med 380:2317\u20132326","journal-title":"N Engl J Med"},{"key":"2061_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/COC.0000000000000015","volume":"39","author":"JA Rauh-Hain","year":"2016","unstructured":"Rauh-Hain\u00a0JA, Vargas\u00a0RJ, Clemmer\u00a0J et al (2016) Mucinous adenocarcinoma of the endometrium compared with endometrioid endometrial cancer: a SEER analysis. Am J Clin Oncol 39:43\u201348","journal-title":"Am J Clin Oncol"},{"issue":"15 Suppl","key":"2061_CR10","doi-asserted-by":"publisher","first-page":"e15575","DOI":"10.1200\/jco.2011.29.15_suppl.e15575","volume":"29","author":"F Musa","year":"2011","unstructured":"Musa\u00a0F, Adams\u00a0B, Huang\u00a0M et\u00a0al (2011) Metastatic potential and prognosis of mucinous adenocarcinoma of the endometrium. J\u00a0Clin Oncol 29(15 Suppl):e15575\u2013e15575","journal-title":"J Clin Oncol"},{"key":"2061_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ygyno.2015.03.041","volume":"137","author":"LA Cantrell","year":"2015","unstructured":"Cantrell\u00a0LA, Blank\u00a0SV, Duska\u00a0LR (2015) Uterine carcinosarcoma: A review of the literature. Gynecol Oncol 137:581\u2013588","journal-title":"Gynecol Oncol"},{"key":"2061_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/IGC.0b013e31821a62dd","volume":"21","author":"AS Felix","year":"2011","unstructured":"Felix\u00a0AS, Stone\u00a0RA, Bowser\u00a0R et al (2011) Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers. Int J Gynecol Cancer 21:877\u2013884","journal-title":"Int J Gynecol Cancer"},{"key":"2061_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ygyno.2005.04.027","volume":"98","author":"F Amant","year":"2005","unstructured":"Amant\u00a0F, Cadron\u00a0I, Fuso\u00a0L et al (2005) Endometrial carcinosarcomas have a\u00a0different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecol Oncol 98:274\u2013280","journal-title":"Gynecol Oncol"},{"key":"2061_CR14","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/cncr.2820710440","volume":"71","author":"FJ Major","year":"1993","unstructured":"Major\u00a0FJ, Blessing\u00a0JA, Silverberg\u00a0SG et al (1993) Prognostic factors in early-stage uterine sarcoma. A gynecologic oncology group study. Cancer 71:1702\u20131709","journal-title":"Cancer"},{"key":"2061_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/1097-0142(19860101)57:1<155::AID-CNCR2820570131>3.0.CO;2-C","volume":"57","author":"WJ Spanos Jr.","year":"1986","unstructured":"Spanos\u00a0WJ Jr., Peters\u00a0LJ, Oswald\u00a0MJ (1986) Patterns of recurrence in malignant mixed m\u00fcllerian tumor of the uterus. Cancer 57:155\u2013159","journal-title":"Cancer"},{"key":"2061_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejca.2022.04.002","volume":"169","author":"\u00c5 \u00c5kesson","year":"2022","unstructured":"\u00c5kesson \u00c5, Adok\u00a0C, Dahm-K\u00e4hler\u00a0P (2022) Increased survival in non-endometrioid endometrial cancer after introducing lymphadenectomy and tailoring radiotherapy\u2014A population-based cohort study. Eur J Cancer 169:54\u201363","journal-title":"Eur J Cancer"},{"key":"2061_CR17","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","volume":"92","author":"HM Keys","year":"2004","unstructured":"Keys\u00a0HM, Roberts\u00a0JA, Brunetto\u00a0VL et\u00a0al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a\u00a0Gynecologic Oncology Group study. Gynecol Oncol 92:744\u2013751","journal-title":"Gynecol Oncol"},{"key":"2061_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ygyno.2012.01.051","volume":"125","author":"O Akbayir","year":"2012","unstructured":"Akbayir\u00a0O, Corbacioglu\u00a0A, Goksedef\u00a0BP et\u00a0al (2012) The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium. Gynecol Oncol 125:400\u2013403","journal-title":"Gynecol Oncol"},{"key":"2061_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1245\/s10434-010-1206-x","volume":"18","author":"SJ Chang","year":"2011","unstructured":"Chang\u00a0SJ, Kong\u00a0TW, Kim\u00a0WY et al (2011) Lymph-vascular space invasion as a\u00a0significant risk factor for isolated para-aortic lymph node metastasis in endometrial cancer: a\u00a0study of 203\u00a0consecutive patients. Ann Surg Oncol 18:58\u201364","journal-title":"Ann Surg Oncol"},{"key":"2061_CR20","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1097\/IGC.0b013e3182a16c93","volume":"23","author":"LE Weinberg","year":"2013","unstructured":"Weinberg\u00a0LE, Kunos\u00a0CA, Zanotti\u00a0KM (2013) Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer. Int J Gynecol Cancer 23:1438\u20131445","journal-title":"Int J Gynecol Cancer"},{"key":"2061_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ygyno.2011.09.017","volume":"124","author":"SR Guntupalli","year":"2012","unstructured":"Guntupalli\u00a0SR, Zighelboim\u00a0I, Kizer\u00a0NT et\u00a0al (2012) Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer. Gynecol Oncol 124:31\u201335","journal-title":"Gynecol Oncol"},{"key":"2061_CR22","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1097\/IGC.0000000000000490","volume":"25","author":"R dos Reis","year":"2015","unstructured":"dos Reis\u00a0R, Burzawa\u00a0JK, Tsunoda\u00a0AT et al (2015) Lymphovascular space invasion portends poor prognosis in low-risk endometrial cancer. Int J Gynecol Cancer 25:1292\u20131299","journal-title":"Int J Gynecol Cancer"},{"key":"2061_CR23","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2090::AID-CNCR29>3.0.CO;2-7","volume":"86","author":"T Hachisuga","year":"1999","unstructured":"Hachisuga\u00a0T, Kaku\u00a0T, Fukuda\u00a0K et\u00a0al (1999) The grading of lymphovascular space invasion in endometrial carcinoma. Cancer 86:2090\u20132097","journal-title":"Cancer"},{"key":"2061_CR24","doi-asserted-by":"publisher","first-page":"100581","DOI":"10.1016\/j.ctarc.2022.100581","volume":"32","author":"G Nogueira-Costa","year":"2022","unstructured":"Nogueira-Costa\u00a0G, Eiriz\u00a0I, Braga\u00a0S (2022) Non-endometrioid endometrial cancer: analysis of different adjuvant treatment modalities. Cancer Treat Res Commun 32:100581","journal-title":"Cancer Treat Res Commun"},{"issue":"18 Suppl","key":"2061_CR25","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1200\/jco.2007.25.18_suppl.5503","volume":"25","author":"T Hogberg","year":"2007","unstructured":"Hogberg\u00a0T, Rosenberg\u00a0P, Kristensen\u00a0G et al (2007) A randomized phase-III study on adjuvant treatment with radiation (RT) \u00b1 chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501\/EORTC 55991). J\u00a0Clin Oncol 25(18 Suppl):5503\u20135503","journal-title":"J Clin Oncol"},{"key":"2061_CR26","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1200\/JCO.21.02050","volume":"40","author":"MA Powell","year":"2022","unstructured":"Powell\u00a0MA, Filiaci\u00a0VL, Hensley\u00a0ML et\u00a0al (2022) Randomized phase III trial of Paclitaxel and carboplatin versus paclitaxel and Ifosfamide in patients with carcinosarcoma of the uterus or ovary: an NRG oncology trial. J\u00a0Clin Oncol 40:968\u2013977","journal-title":"J Clin Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02061-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-023-02061-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02061-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T17:05:31Z","timestamp":1692896731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-023-02061-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2061"],"URL":"https:\/\/doi.org\/10.1007\/s00066-023-02061-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"So Jung Lee, Hye Jin Kang, Yoo-Kang Kwak, Myungso Kim, and Jisang Kim declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of the Catholic Medical Center Ethics Committee (IRB no. OC22RASI0123).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}